Takeda Pharmaceutical Company Limited Stock Deutsche Boerse AG
Equities
TKD
JP3463000004
Pharmaceuticals
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.18 EUR | +0.35% | -0.25% | -6.29% |
05-16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
05-15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
Sales 2024 | 4,264B 27.17B 25.01B 37.06B | Sales 2025 * | 4,161B 26.51B 24.4B 36.16B | Capitalization | 6,513B 41.5B 38.2B 56.6B |
---|---|---|---|---|---|
Net income 2024 | 144B 918M 845M 1.25B | Net income 2025 * | 127B 811M 746M 1.11B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.03B 22.12B 32.77B | Net Debt 2025 * | 4,125B 26.28B 24.19B 35.85B | EV / Sales 2025 * | 2.56 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
48.8
x | Employees | 49,095 |
Yield 2024 * |
4.53% | Yield 2025 * |
4.62% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +0.37% | ||
1 week | -0.25% | ||
Current month | -1.79% | ||
1 month | -1.11% | ||
3 months | -10.47% | ||
6 months | -4.66% | ||
Current year | -6.29% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 14-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 22-01-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 16-05-31 | |
Ian Clark
BRD | Director/Board Member | 62 | 18-12-31 |
Steven Gillis
BRD | Director/Board Member | 71 | 18-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 24.12 | +0.08% | 0 |
24-05-27 | 24.1 | -0.45% | 0 |
24-05-24 | 24.21 | +0.41% | 0 |
24-05-23 | 24.11 | -0.21% | 10 |
24-05-22 | 24.16 | -0.08% | 1,000 |
Delayed Quote Deutsche Boerse AG, May 28, 2024 at 03:20 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.70% | 727B | |
-6.98% | 354B | |
+16.13% | 328B | |
+0.10% | 277B | |
+13.74% | 243B | |
+7.39% | 205B | |
-6.22% | 203B | |
+4.38% | 164B | |
-1.25% | 164B |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock